Selected article for: "dose dependent manner and present study"

Author: Wu, Beibei; Wang, Liyin; Jiang, Lili; Dong, Lili; Xu, Fengli; Lu, Yili; Jin, Jiahui; Wang, Zhanyue; Liang, Guang; Shan, Xiaoou
Title: n-butanol extract from Folium isatidis inhibits the lipopolysaccharide-induced downregulation of CXCR1 and CXCR2 on human neutrophils
  • Document date: 2017_10_25
  • ID: w85t4zz6_14
    Snippet: n-butanol extract from Folium isatidis prevents the LPS-induced downregulation of CXCR1, CXCR2 and CD62L. CXCR1, CXCR2 and CD62L may be important in sepsis, however, whether n-butanol extract affects these chemokine receptors remains to be elucidated. Therefore, the present study assessed the effect of the extract on the expression of CXCR1, CXCR2 and CD62L. The isolated neutrophils were pre-incubated with either vehicle or increasing concentrati.....
    Document: n-butanol extract from Folium isatidis prevents the LPS-induced downregulation of CXCR1, CXCR2 and CD62L. CXCR1, CXCR2 and CD62L may be important in sepsis, however, whether n-butanol extract affects these chemokine receptors remains to be elucidated. Therefore, the present study assessed the effect of the extract on the expression of CXCR1, CXCR2 and CD62L. The isolated neutrophils were pre-incubated with either vehicle or increasing concentrations of extract (100, 250 and 500 µg/ml) for 2 h, and were subsequently treated with LPS (0.5 µg/ml) for 4 h. Subsequent analysis of the cells using flow cytometry indicated that the extract inhibited the LPS-induced downregulation of CXCR1, CXCR2 and CD62L ( Fig. 2A-C) in a dose-dependent manner.

    Search related documents:
    Co phrase search for related documents
    • chemokine receptor and flow cytometry: 1, 2, 3, 4, 5, 6, 7, 8
    • chemokine receptor and flow cytometry cell: 1, 2
    • chemokine receptor and folium isatidis: 1, 2, 3
    • chemokine receptor and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • chemokine receptor and subsequent analysis: 1
    • dose dependent manner and flow cytometry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • dose dependent manner and flow cytometry cell: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • dose dependent manner and folium isatidis: 1
    • dose dependent manner and increase concentration: 1, 2, 3
    • dose dependent manner and LPS induce: 1
    • dose dependent manner and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • extract increase concentration and increase concentration: 1
    • flow cytometry and folium isatidis: 1, 2
    • flow cytometry and increase concentration: 1, 2, 3
    • flow cytometry and LPS induce: 1
    • flow cytometry and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • flow cytometry and subsequent analysis: 1, 2, 3, 4, 5, 6, 7
    • flow cytometry cell and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • flow cytometry cell and subsequent analysis: 1, 2